NVIV
$1.47
Invivo Therapeutics Holdings
($.07)
(4.55%)
Earnings Details
1st Quarter March 2020
Tweet Share Watch
Summary

Invivo Therapeutics Holdings (NVIV) Recent Earnings

Invivo Therapeutics Holdings (NVIV) reported a 1st Quarter March 2020 loss of $2.47 per share on revenue of $0.0 million..

InVivo Therapeutics Holdings Corp. develops novel biomaterial technologies for the treatment of spinal cord injuries and hydrogels for therapeutics delivery.

Results
Reported Earnings
($2.47)
Earnings Whisper
-
Consensus Estimate
Reported Revenue
Revenue Estimate
Growth
Earnings Growth
Revenue Growth
Power Rating
Grade
Earnings Release